Advertisement

Topics

InNexus Biotechnology, Inc. Company Profile

13:56 EDT 18th September 2018 | BioPortfolio

approaches that add secondary properties to monoclonal antibodies (binding is a primary property) and applies to virtually every antibody product currently in development. Adding these secondary properties can increase the potency of antibodies or add new properties such as the ability to penetrate into living cells.
As an example, InNexus utilized SAT with a humanized monoclonal antibody, licensed by the FDA for the treatment of non-Hodgkin’s, B-Cell lymphoma. SAT greatly enhanced the killing of cancer cells in culture by this antibody, dramatically increasing its potential potency

Location

13208 East Shea Boulevard, Suite 200The Mayo Clinic MCCRB Building
Scottsdale
Arizona
85259
United States of America

Contact

Fax: 1-425-696-0068
Email: business@innexusbiotech.com


News Articles [95 Associated News Articles listed on BioPortfolio]

Biotechnology and the Environment: Can Biotech Save the Planet?

Think biotechnology, you probably think cutting-edge development of drugs to treat diseases. Yet in 2007, a U.S. EPA report noted that industrial biotechnology and biobased manufacturing are more effi...

BIO: Growth of Australia in biotechnology sector and the similarities with the US

In this episode of PharmaTelevision News Review, Fintan Walton talks to James C Greenwood, President and CEO of Biotechnology Industry Organisation (BIO). They discuss: • Growth of Australia in bio...

Looking at Nanotechnology in Biotechnology

For some time, the difference between a biotechnology company and a pharmaceutical company was straightforward. A biotechnology focused on developing drugs with a biological basis. Pharmaceutical comp...

Become an advocate for biotechnology

Learn more about key policy issues affecting biotechnology in Washington, D.C., and state capitals around the country.  -More- 

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum. K2Biomedical will operate as Orion Biotechnology Poland,...Read More... The post M&As this week: O...

Legislators Bat for the Advancement of Agri-biotech in PH

Filipino lawmakers on Monday called for the continued advancement of biotechnology in the country during the opening of the Biotechnology Exhibit in the House of Representatives themed Bioteknolohiya:...

Consistency in Biotech Reporting Vital in Cultivating Public Awareness

The Kenya Chapter of Open Forum on Agricultural Biotechnology in Africa (OFAB) has recognized journalists for their consistent reporting on agricultural biotechnology. The event, held in Nairobi on Au...

Synthetic Biology as Innovation in Industrial Biotechnology

Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that have made ...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Salivary Antioxidant Capacity Before and After Complete Dental Rehabilitation

Salivary samples were obtained from 20 children in their fifth year of life diagnosed S-ECC and 20 age and sex matched controls. Complete dental rehabilitation under general anesthesia was...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

Companies [884 Associated Companies listed on BioPortfolio]

InNexus Biotechnology Inc.

InNexus is a leading drug development company commercializing the next generation of monoclonal antibodies based on its DXL™ and Transmab™ technology to improve the pote...

InNexus Biotechnology, Inc.

approaches that add secondary properties to monoclonal antibodies (binding is a primary property) and applies to virtually every antibody product currently in development. Adding these secondary prope...

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Bioteknologinemnda

The Norwegian Biotechnology Advisory BoardThe Norwegian Biotechnology Advisory Board is an independent body consisting of 24 members appointed by the Norwegian government. Each member has a background...

More Information about "InNexus Biotechnology, Inc." on BioPortfolio

We have published hundreds of InNexus Biotechnology, Inc. news stories on BioPortfolio along with dozens of InNexus Biotechnology, Inc. Clinical Trials and PubMed Articles about InNexus Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InNexus Biotechnology, Inc. Companies in our database. You can also find out about relevant InNexus Biotechnology, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record